Bruce Rogers

Chief Scientific Officer at Morphic Therapeutic

Bruce Rogers, PhD is Chief Scientific Officer at Morphic Therapeutic Inc. He brings over 20 years of drug discovery experience across pre-clinical and early stage clinical development programs, medicinal chemistry, biology, partnering and R&D strategy. He was most recently the Head of Neuro-Opportunities at Pfizer, where he led a team focused on entrepreneurial approaches to long standing CNS biology challenges, including direct brain delivery of protein therapeutics for PD and oncology approaches. Bruce spent 16 years in positions of increasing responsibility within the medicinal chemistry organization at Pfizer and Pharmacia, and during his time there led multiple discovery and early clinical development teams, with his group advancing over a dozen small molecule candidates into clinical trials for a broad range of neuroscience indications. Bruce has co-authored more than 50 scientific publications, reviews and abstracts and is a co-inventor on over 40 patents and patent applications. He holds a BA in chemistry from the University of Minnesota, a PhD in organic chemistry from the University of California at Irvine. He was a National Institutes of Health postdoctoral fellow at the University of California prior to joining the pharmaceutical industry.

Links

Previous companies

University of California, Irvine logo
3M logo
Pfizer logo

Timeline

  • Chief Scientific Officer

    Current role

View in org chart